Literature DB >> 33111076

Highly Efficient CRISPR-Associated Protein 9 Ribonucleoprotein-Based Genome Editing in Euglena gracilis.

Toshihisa Nomura1,2, Mizuki Yoshikawa2, Kengo Suzuki2,3, Keiichi Mochida1,2,4,5,6.   

Abstract

Euglena gracilis, a unicellular phytoflagellate microalga, is a promising biomaterial for foods, feeds, and biofuels. However, targeted mutagenesis in this species has been a long-standing challenge. We recently developed a transgene-free, highly efficient, genome editing method for E. gracilis using CRISPR/Cas9 ribonucleoproteins (RNPs). Our method achieved mutagenesis rates of approximately 80% or more through an electroporation-based direct delivery of Cas9 RNPs. Therefore, this method is suitable for basic research and industrial applications, such as the breeding of Euglena. For complete details on the use and execution of this protocol, please refer to Nomura et al. (2019).
© 2020 The Author(s).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33111076      PMCID: PMC7580193          DOI: 10.1016/j.xpro.2020.100023

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


BEFORE YOU BEGIN

CRITICAL: All procedures in this protocol are performed aseptically on a clean bench.

Culture of Euglena gracilis

TIMING: 3–7 days Euglena gracilis Z strain was cultured using KH medium (Koren, 1967) adjusted to pH 5.5 with potassium hydroxide on a rotary shaker (120 rpm) at 28°C under continuous light (50 μmol photons m−2 s−1) conditions. The culture was maintained by inoculating 100 μL into 50 mL of fresh KH medium every week (Figures 1A and 1C).
Figure 1

Liquid Culture of Euglena gracilis

Just after the E. gracilis cells were transferred to fresh KH medium (A), after culturing for 3 days (B), and 7 days (C).

Liquid Culture of Euglena gracilis Just after the E. gracilis cells were transferred to fresh KH medium (A), after culturing for 3 days (B), and 7 days (C). For the direct delivery of Cas9 ribonucleoproteins (RNPs) by electroporation, E. gracilis cells that have been cultured for 3 days are used (Figure 1B).

KEY RESOURCES TABLE

MATERIALS AND EQUIPMENT

Design of the Target Sequence for crRNA Synthesis

Normally, the target sequence used is 20 bp upstream of the protospacer adjacent motif sequence (5’-NGG-3’). The GC content of the target sequence should be 40%–60%. It is recommended to design two or more target sequences for one target gene.

Preparation of Stock crRNA and tracrRNA Solutions (100 μM) with Nuclease-free Duplex Buffer

Alt-R CRISPR-Cas9 crRNA (CRISPR RNA) and tracrRNA (trans-activating crRNA) were synthesized by Integrated DNA Technologies (IDT), and a 100-μM solution was prepared using nuclease-free duplex buffer (IDT). The stock solution can be stored at −20°C.

Preparation of the Modified CM Medium (Cramer and Myers, 1952)

Prepare a modified CM medium with the following composition. Composition of Modified CM Medium Adjust the pH to 5.5 with 10% sulfuric acid. Autoclave at 121°C for 15 min. CM medium can be stored at 20°C–25°C.

Preparation of Electroporation Solution

Prepare a 0.3-M sucrose solution and sterilize using a 0.2-μm pore size syringe filter. Mix the modified CM medium and the filter sterilized sucrose solution at a ratio of 3:2 (v/v). The electroporation solution can be stored at 20°C–25°C. This protocol can be implemented using other thermal cyclers, plant growth chambers, and orbital shakers with equivalent device performance as the above equipment.

STEP-BY-STEP METHOD DETAILS

Preparation of Cas9 RNPs

TIMING: 30 min This step describes the procedure to prepare Cas9 RNP complexes for electroporation. Equal amounts of crRNA and tracrRNA solution (100 μM stock) were mixed in a 0.2-mL PCR tube. An example of the reagent amounts used for one electroporation reaction is shown in Table 1.
Table 1

Alt-R CRISPR-Cas9 crRNA Reagent Volumes Used in Each Electroporation Reaction

Reagent (μM)Volume (μL)
Alt-R CRISPR-Cas9 crRNA (100)0.6
Alt-R CRISPR-Cas9 tracrRNA (100)0.6
Total volume1.2
Alt-R CRISPR-Cas9 crRNA Reagent Volumes Used in Each Electroporation Reaction The mixture was heated at 95°C for 5 min and then cooled to 20°C using a thermal cycler with a ramp rate setting of −0.1°C/s. Heated crRNA-tracrRNA complex can be cooled on the bench at 20°C–25°C. Alt-R S.p. Cas9 Nuclease V3 (IDT, 62 μM solution) was added to the cooled gRNA complex. Examples of the amount of reagent used for one electroporation reaction are shown in Table 2.
Table 2

crRNA-tracrRNA Complex and Alt-R CRISPR-Cas9 crRNA Reagent Volumes Used in Each Electroporation

Reagent (μM)Volume (μL)
crRNA-tracrRNA complex1.2
Alt-R S.p. Cas9 Nuclease V3 (62)0.8
Total volume2.0
crRNA-tracrRNA Complex and Alt-R CRISPR-Cas9 crRNA Reagent Volumes Used in Each Electroporation To form the Cas9 RNP complexes, the mixture was incubated for 15 min at 20°C–25°C. PAUSE POINT: The Cas9 RNP complex can be stored at −80°C for 6 months.

Direct Delivery of Cas9 RNPs by Electroporation

TIMING: 10–20 min This step describes the procedure to deliver Cas9 RNPs to E. gracilis cells by electroporation. E. gracilis was cultured in KH medium (pH 5.5) for 3 days (Figure 1B), and 1 mL of the cell culture was transferred to a 1.5 mL tube (Figure 2A).
Figure 2

Preparation of the Suspension of E. gracilis Cells for Electroporation

Transfer of cultured E. gracilis cells (A), E. gracilis cells pellet after centrifugation (B), Resuspended E. gracilis cells (C).

Preparation of the Suspension of E. gracilis Cells for Electroporation Transfer of cultured E. gracilis cells (A), E. gracilis cells pellet after centrifugation (B), Resuspended E. gracilis cells (C). The optical density at 600 nm of 10-fold dilution of E. gracilis after 3 days of culture is approximately 0.5–0.7. The cell culture sample was centrifuged at 400 × g for 30 s (Figure 2B), and the supernatant was removed. The cells were then resuspended with the addition of 1 mL of electroporation solution. The cell suspension was centrifuged at 400 × g for 30 s, and the supernatant was removed. The cells were resuspended in electroporation solution at a concentration of 1 × 106 cells/mL (Figure 2C). Then, 48 μL of the E. gracilis suspension was transferred to 0.2 mL new tube (Figure 3A).
Figure 3

Preparation Procedure for Cas9 RNPs Introduction by Electroporation

Transfer of resuspended E. gracilis cells (A), Addition of Cas9 RNPs (B), Transfer of Cas9 RNPs and cell suspension mixture to cuvette (C), Tapping of the cuvette (D).

Preparation Procedure for Cas9 RNPs Introduction by Electroporation Transfer of resuspended E. gracilis cells (A), Addition of Cas9 RNPs (B), Transfer of Cas9 RNPs and cell suspension mixture to cuvette (C), Tapping of the cuvette (D). Finally, 2 μL of Cas9 RNP complex solution was added and the solution was mixed several times by pipetting (Figure 3B). Alternatively, to prevent the loss of Cas9 RNPs solution, the E. gracilis suspension can be directly transferred to a tube containing 2 μL of the RNP complex solution. CRITICAL: The amount of Cas9 RNPs is important. If the RNP amount is reduced, the genome editing efficiency will decrease. The Cas9 RNPs and E. gracilis suspension mixture was transferred to a 2-mm gap cuvette (EC-002; Nepa Gene) (Figure 3C). The cuvette was tapped to drop the Cas9 RNP and cell suspension mixture to the bottom of the cuvette (Figure 3D). A NEPA21 Super Electroporator (Nepa Gene) was used for the introduction of the RNP complexes. The electroporation conditions are shown in Table 3 and Figure 4A.
Table 3

Settings for the NEPA21 Super Electroporator

Poring PulseTransfer Pulse
Voltage (V)30020
Pulse length (ms)550
Pulse interval (ms)5050
Number of pulses25
Decay rate (%)4040
Polarity switching+±
Figure 4

Operation Procedure for the Electroporator

Settings of the electroporator (A), Insertion of the cuvette into the electrode chamber (B), Measurement of the impedance value (C), Initiation of electroporation (D).

Settings for the NEPA21 Super Electroporator Operation Procedure for the Electroporator Settings of the electroporator (A), Insertion of the cuvette into the electrode chamber (B), Measurement of the impedance value (C), Initiation of electroporation (D). The cuvette was inserted into the electrode chamber (Figure 4B), and the “Ω” switch was pressed. The impedance value was usually approximately 0.4–0.5 kΩ (Figure 4C). The “Start” switch was pressed to initiate electroporation (Figure 4D). After electroporation, 1 mL of KH medium (pH 5.5) was added to the cuvette (Figures 5A and 5B).
Figure 5

Procedure of Recovery Culture after Electroporation

Ejection of the cuvette from the electrode chamber (A), Addition of KH medium (B), Transfer of cell suspension to well plate (C), Covering of culture plate with aluminum foil (D) and recovery culture on a rotary shaker (E).

Procedure of Recovery Culture after Electroporation Ejection of the cuvette from the electrode chamber (A), Addition of KH medium (B), Transfer of cell suspension to well plate (C), Covering of culture plate with aluminum foil (D) and recovery culture on a rotary shaker (E). The cell suspension was transferred to a 12-well plate (Figure 5C) and cultured on a rotary shaker (120 rpm) at 28°C under dark conditions (by covering with aluminum foil) for 24–72 h (Figures 5D and 5E). Seal the plate with parafilm and surgical tape to prevent evaporation of the culture medium.

Single-Stranded Oligodeoxynucleotide-Mediated Knockin (Optional)

TIMING: 5 min The high-efficiency knockin of short sequences (∼50 bp) is possible by introducing the Cas9 RNPs and single-stranded oligodeoxynucleotides (ssODNs) with 50 bp upstream and downstream homology sequence arms of the target site (Nomura et al., 2019). ssODNs were synthesized by IDT, and a 200 μM solution was prepared with nuclease-free duplex buffer (IDT) For electroporation, 2 μL of RNP complex solution and 1 μL of 200 μM ssODN stock solution were added to 47 μL of the E. gracilis suspension. It is possible to rewrite the target base using an ssODN containing the nucleotide substitutions. In this case, to prevent re-cleavage by Cas9 RNPs, two or more base mismatches are required in the seed region of the target sequence in ssODN.

Detection of Targeted Mutagenesis

TIMING: 3 h or more For the detection of mutagenesis at on-target sites in Cas9 RNP-introduced E. gracilis, a T7 endonuclease I (T7EI) mismatch cleavage assay was performed using an Alt-R Genome Editing Detection Kit (IDT). The DNA template was extracted from the small E. gracilis cells pellet (Figure 6A) using a Kaneka Easy DNA Extraction Kit v.2 (Kaneka).
Figure 6

Example of T7 Endonuclease I Mismatch Cleavage Assay

Small E. gracilis cells pellet after recovery culture for DNA extraction (A) and example of T7E1 assay results (B).

Example of T7 Endonuclease I Mismatch Cleavage Assay Small E. gracilis cells pellet after recovery culture for DNA extraction (A) and example of T7E1 assay results (B). Alternatively, another DNA extraction kit can be used. DNA fragments, including the target sites, were amplified by Tks Gflex DNA Polymerase (Takara Bio) using the specific primer set. Using the amplified DNA fragments, the T7EI treatment was performed according to the product manufacturer’s instructions. The digested DNA fragments were monitored using 1% agarose gel electrophoresis (Figure 6B). Because T7EI does not recognize single-base indels, the T7EI assay estimates a lower editing efficiency rate.

Pure-Line (Single-Cell-Derived Clone) Isolation from a Single E. gracilis Cell

TIMING: 1 week or more This step describes how to obtain a single-cell-derived clone in E. gracilis. Following electroporation after 24–72 h culture in KH medium, a single cell was isolated using a micro pick-and-place system (Nepa Gene) (Figures 7A and 7B).
Figure 7

Procedure of Pure-Line Isolation from Single Cell of E. gracilis

A single E. gracilis cell isolation using a micro pick-and-place system (A and B), Culture from isolated single E. gracilis cell (C and D).

Procedure of Pure-Line Isolation from Single Cell of E. gracilis A single E. gracilis cell isolation using a micro pick-and-place system (A and B), Culture from isolated single E. gracilis cell (C and D). A single cell of E. gracilis can be manually isolated using a glass capillary pipette or cell sorter. The isolated single cell was cultured for ≥7 days using KH medium to obtain a pure line (Figures 7C and 7D). Contamination can be suppressed by using KH medium at pH 3.5 for culture.

Genotyping by Sanger Sequencing

TIMING: 3 days This step describes Sanger sequencing for genotyping of E. gracilis. The DNA template was extracted from a 5–10-μL cell pellet volume of E. gracilis using the Kaneka Easy DNA Extraction Kit v.2 (Kaneka). DNA fragments, including the target sites, were amplified by Tks Gflex DNA Polymerase using the specific primer set for target site. A PCR product length of approximately 500–1000 bp is suitable for genotyping. To clone the PCR products, we used a CloneJET PCR cloning kit (Thermo Fisher Scientific). Colonies were then selected with the vector containing the insert DNA by colony PCR. Each plasmid was extracted using a plasmid DNA extraction Mini Kit (FAVORGEN), and sequences were determined using Sanger sequencing.

EXPECTED OUTCOMES

Euglena gracilis, a unicellular phototrophic protist, is a promising material for foods, feeds, and biofuels. However, the development of a targeted mutagenesis method in this species has been a long-standing challenge. Among the current genetic manipulation technologies, genome editing by the direct delivery of RNPs has various advantages, including time effectiveness, a low cytotoxicity, a high efficiency, and the reduction of off-target effects (Jeon et al., 2017). In our method, insertion and/or deletion (Indel) mutations rate of 77.7%–90.1% has been detected by amplicon sequencing in two different target sequences in the EgGSL2 gene (Nomura et al., 2019). Therefore, our developed RNP-based genome editing in E. gracilis opens up new avenues to reveal the functions of genes. In addition, based on our developed method, it will be possible to develop convenient CRISPR-based technology for the basic research of E. gracilis, such as chromosome visualization and epigenome editing (Doudna and Charpentier, 2014, Wang et al., 2016). Furthermore, RNP-based genome editing without transgenes is suitable for industrial use because it can potentially bypass the regulation of genetically modified organisms. Thus, RNP-based genome editing in E. gracilis paves the way for improving its industrially relevant traits to promote production of bio-based material.

LIMITATIONS

Because the published genome sequence information of E. gracilis strain Z1 appears to be fragmented (Ebenezer et al., 2019), it has been difficult to precisely assess the off-target effects of genome editing in E. gracilis. This limitation will be resolved by improving the genome assembly of E. gracilis. To confirm a phenotypic change by on-target in genome-edited strains, several target sites for a target gene should be examined. Off-target effect can be suppressed by reducing the amount of RNPs and using a truncated (∼18 bp) target sequence (Fu et al. 2014). Furthermore, off-target can be reduced by the use of S.p. HiFi Cas9 Nuclease V3 (IDT). In case a different strain of E. gracilis is used, efficiency may decrease due to differences in cell properties, such as growth rate. Therefore, in such cases, the protocol for each strain needs to be optimized. In addition, there is a possibility that parts of the genomic DNA sequence vary depending on the strain of E. gracilis used. Before designing the target sequence, it is also necessary to obtain information on the surrounding DNA sequence of the target site by cloning and sequencing. The maximum length of single-stranded DNAs that can be knocked in in our protocol remains undetermined. It is generally considered that the homology arm needs to be lengthened according to the length of the DNA to be knocked in. Although the present method has enabled us to precisely knockin a DNA fragment of at least 50 bp in length, an improvement in our method for the knockin of longer DNAs in E. gracilis will provide opportunities to engineer E. gracilis cells to enhance its productivity and function.

TROUBLESHOOTING

Problem

Low mutagenesis efficiency

Potential Solution

In cases when the genome-edited cells exhibit a slow growth phenotype, the mutagenesis efficiency could be decreased due to the faster growth of wild-type cells. This problem can be solved by earlier cell isolation (e.g., 24 h) after the introduction of Cas9 RNPs. On the other hand, if the performance of the designed target sequence is poor it can be improved by doubling the amount (4 μL/total 50 μL reaction) of Cas9 RNPs used for electroporation.
REAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, Peptides, and Recombinant Proteins

Alt-R CRISPR-Cas9 tracrRNAIntegrated DNA Technologies1072532
Alt-R CRISPR-Cas9 crRNAIntegrated DNA TechnologiesN/A
Alt-R S.p. Cas9 Nuclease V3Integrated DNA Technologies1081058
Ultramer DNA OligosIntegrated DNA TechnologiesN/A
Kaneka Easy DNA Extraction Kit v.2KanekaKN-T110005
Tks Gflex DNA PolymeraseTakara BioR060A
CloneJET PCR Cloning KitThermo ScientificK1231
Alt-R Genome Editing Detection KitIntegrated DNA Technologies1075931
(NH4)2HPO4FUJIFILM Wako Pure Chemical Corporation016-03325
KH2PO4FUJIFILM Wako Pure Chemical Corporation169-04245
MgSO4・7H2OFUJIFILM Wako Pure Chemical Corporation131-00405
CaCl2FUJIFILM Wako Pure Chemical Corporation038-24985
Fe2 (SO4)3・nH2OFUJIFILM Wako Pure Chemical Corporation091-02832
MnCl2・4H2OFUJIFILM Wako Pure Chemical Corporation139-00722
ZnSO4・7H2OFUJIFILM Wako Pure Chemical Corporation264-00402
CoSO4・7H2OFUJIFILM Wako Pure Chemical Corporation032-03802
Na2MoO4・2H2OFUJIFILM Wako Pure Chemical Corporation196-02472
CuSO4・5H2OFUJIFILM Wako Pure Chemical Corporation039-04412
Vitamin B1 (Thiamin)FUJIFILM Wako Pure Chemical Corporation201-00852
Vitamin B12FUJIFILM Wako Pure Chemical Corporation226-00343
10% Sulfuric acidFUJIFILM Wako Pure Chemical Corporation198-11705
Potassium hydroxideFUJIFILM Wako Pure Chemical Corporation168-21815

Experimental Models: Organisms/Strains

Euglena gracilis ZInstitute of Applied Microbiology (IAM) culture collectionIAM E-6, NIES-48

Other

BioTRONNK systemsLPH-411SP
Shake-LRTAITEC0054809-000
T100 Thermal CyclerBio-Rad#1861096
NEPA21 Super ElectroporatorNepa GeneN/A

Composition of Modified CM Medium

ReagentWeight per L
(NH4)2HPO41.0 g
KH2PO41.0 g
MgSO4・7H2O0.2 g
CaCl20.02 g
Fe2 (SO4)3・nH2O3 mg
MnCl2・4H2O1.8 mg
ZnSO4・7H2O0.4 mg
CoSO4・7H2O1.5 mg
Na2MoO4・2H2O0.2 mg
CuSO4・5H2O0.02 mg
Vitamin B10.1 mg
Vitamin B120.0005 mg

Adjust the pH to 5.5 with 10% sulfuric acid.

Autoclave at 121°C for 15 min.

  6 in total

Review 1.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

Review 2.  CRISPR/Cas9 in Genome Editing and Beyond.

Authors:  Haifeng Wang; Marie La Russa; Lei S Qi
Journal:  Annu Rev Biochem       Date:  2016-04-25       Impact factor: 23.643

Review 3.  Current status and perspectives of genome editing technology for microalgae.

Authors:  Seungjib Jeon; Jong-Min Lim; Hyung-Gwan Lee; Sung-Eun Shin; Nam Kyu Kang; Youn-Il Park; Hee-Mock Oh; Won-Joong Jeong; Byeong-Ryool Jeong; Yong Keun Chang
Journal:  Biotechnol Biofuels       Date:  2017-11-14       Impact factor: 6.040

4.  Highly efficient transgene-free targeted mutagenesis and single-stranded oligodeoxynucleotide-mediated precise knock-in in the industrial microalga Euglena gracilis using Cas9 ribonucleoproteins.

Authors:  Toshihisa Nomura; Komaki Inoue; Yukiko Uehara-Yamaguchi; Koji Yamada; Osamu Iwata; Kengo Suzuki; Keiichi Mochida
Journal:  Plant Biotechnol J       Date:  2019-06-11       Impact factor: 9.803

5.  Transcriptome, proteome and draft genome of Euglena gracilis.

Authors:  ThankGod E Ebenezer; Martin Zoltner; Alana Burrell; Anna Nenarokova; Anna M G Novák Vanclová; Binod Prasad; Petr Soukal; Carlos Santana-Molina; Ellis O'Neill; Nerissa N Nankissoor; Nithya Vadakedath; Viktor Daiker; Samson Obado; Sara Silva-Pereira; Andrew P Jackson; Damien P Devos; Julius Lukeš; Michael Lebert; Sue Vaughan; Vladimίr Hampl; Mark Carrington; Michael L Ginger; Joel B Dacks; Steven Kelly; Mark C Field
Journal:  BMC Biol       Date:  2019-02-07       Impact factor: 7.431

6.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.

Authors:  Yanfang Fu; Jeffry D Sander; Deepak Reyon; Vincent M Cascio; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-01-26       Impact factor: 54.908

  6 in total
  2 in total

Review 1.  A Synthetic Biology Perspective on the Bioengineering Tools for an Industrial Microalga: Euglena gracilis.

Authors:  Zhenfan Chen; Jiayi Zhu; Ming Du; Zixi Chen; Qiong Liu; Hui Zhu; Anping Lei; Jiangxin Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-06

2.  Agrobacterium tumefaciens-Mediated Nuclear Transformation of a Biotechnologically Important Microalga-Euglena gracilis.

Authors:  Ina Becker; Binod Prasad; Maria Ntefidou; Viktor Daiker; Peter Richter; Michael Lebert
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.